⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RCKT News
Rocket Pharmaceuticals, Inc. Common Stock
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
prnewswire.com
BEAM
CRSP
RCKT
SDGR
Rocket Pharmaceuticals to Participate in the 8 th Annual Evercore Healthcare Conference
businesswire.com
RCKT
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
businesswire.com
RCKT
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
businesswire.com
RCKT
RCKT
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
RCKT
RCKT
Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm
prnewswire.com
RCKT